Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 533

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 12
Chunk 533
---
- 
  
    Outstanding as of December 31, 2024 
     1,359,375  
    $0.80  
     0.93 

    F-20

JUPITER
NEUROSCIENCES, INC.

NOTES
TO FINANCIAL STATEMENTS

December
31, 2024 and 2023

Note
6 – Stockholders’ Equity (Deficit), continued

Restricted
Stock Units

On
September 29, 2023, the Company issued an aggregate of 1,399,834 restricted stock units with a grant date value of $1.33 per unit in
exchange for the forgiveness of accrued compensation. Pursuant to the amendment dated December 18, 2023, the restricted stock units shall
vest on the on earlier event of either the occurrence of an initial public offering or in the event of change of control of the Company.
The restricted stock units have an aggregate grant date fair value of $1,866,445.

On
December 18, 2023, the Company terminated 1,399,384 restricted stock units and issued an aggregate of 1,618,537 restricted stock units
with a grant date value of $1.33 in exchange for the forgiveness of accrued compensation. The restricted stock units shall vest on the
earlier event of either the expiration of the lock-up period by the underwriters after the initial public offering or in the event of
change of control of the Company. The restricted stock units have an aggregate grant date fair value of $2,158,050.

On
March 15, 2024, the Company issued 7,500 restricted stock units with a grant date value of $1.33 per unit in exchange for the forgiveness
of accrued compensation. The restricted stock units shall vest on the earlier event of either the expiration of the lock-up period
by the underwriters after the initial public offering or in the event of change of control of the Company.

As
of December 31, 2024, the Company had an aggregate of 1,626,037 restricted stock units outstanding with an aggregate fair value of $2,195,550.

Note
7 – Income Taxes 

A
reconciliation of income taxes at the U.S. federal statutory rate to the benefit for income taxes is as follows:

Schedule
of Income Tax Provision

    2024  
    2023 
  
    Federal 
     21.00%